These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 34791767)

  • 21. Inhibitors of endocannabinoid-metabolizing enzymes reduce precipitated withdrawal responses in THC-dependent mice.
    Schlosburg JE; Carlson BL; Ramesh D; Abdullah RA; Long JZ; Cravatt BF; Lichtman AH
    AAPS J; 2009 Jun; 11(2):342-52. PubMed ID: 19430909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guanfacine decreases symptoms of cannabis withdrawal in daily cannabis smokers.
    Haney M; Cooper ZD; Bedi G; Herrmann E; Comer SD; Reed SC; Foltin RW; Levin FR
    Addict Biol; 2019 Jul; 24(4):707-716. PubMed ID: 29659126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacotherapies for cannabis dependence.
    Nielsen S; Gowing L; Sabioni P; Le Foll B
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD008940. PubMed ID: 30687936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabis use, abuse, and withdrawal: Cannabinergic mechanisms, clinical, and preclinical findings.
    Kesner AJ; Lovinger DM
    J Neurochem; 2021 Jun; 157(5):1674-1696. PubMed ID: 33891706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Varenicline and nabilone in tobacco and cannabis co-users: effects on tobacco abstinence, withdrawal and a laboratory model of cannabis relapse.
    Herrmann ES; Cooper ZD; Bedi G; Ramesh D; Reed SC; Comer SD; Foltin RW; Haney M
    Addict Biol; 2019 Jul; 24(4):765-776. PubMed ID: 30378231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Withdrawal symptoms do not predict relapse among subjects treated for cannabis dependence.
    Arendt M; Rosenberg R; Foldager L; Sher L; Munk-Jørgensen P
    Am J Addict; 2007; 16(6):461-7. PubMed ID: 18058411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cannabis withdrawal syndrome.
    Budney AJ; Hughes JR
    Curr Opin Psychiatry; 2006 May; 19(3):233-8. PubMed ID: 16612207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Nabiximols as a substitute for cannabis].
    Dumont GJH
    Ned Tijdschr Geneeskd; 2020 Sep; 164():. PubMed ID: 33201625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Marijuana withdrawal in humans: effects of oral THC or divalproex.
    Haney M; Hart CL; Vosburg SK; Nasser J; Bennett A; Zubaran C; Foltin RW
    Neuropsychopharmacology; 2004 Jan; 29(1):158-70. PubMed ID: 14560320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sex differences in cannabis withdrawal symptoms among treatment-seeking cannabis users.
    Herrmann ES; Weerts EM; Vandrey R
    Exp Clin Psychopharmacol; 2015 Dec; 23(6):415-21. PubMed ID: 26461168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survey of Patients Employing Cannabigerol-Predominant Cannabis Preparations: Perceived Medical Effects, Adverse Events, and Withdrawal Symptoms.
    Russo EB; Cuttler C; Cooper ZD; Stueber A; Whiteley VL; Sexton M
    Cannabis Cannabinoid Res; 2022 Oct; 7(5):706-716. PubMed ID: 34569849
    [No Abstract]   [Full Text] [Related]  

  • 32. Cannabinoid Hyperemesis Syndrome Survey and Genomic Investigation.
    Russo EB; Spooner C; May L; Leslie R; Whiteley VL
    Cannabis Cannabinoid Res; 2022 Jun; 7(3):336-344. PubMed ID: 34227878
    [No Abstract]   [Full Text] [Related]  

  • 33. Review of the validity and significance of cannabis withdrawal syndrome.
    Budney AJ; Hughes JR; Moore BA; Vandrey R
    Am J Psychiatry; 2004 Nov; 161(11):1967-77. PubMed ID: 15514394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nicotine patch for cannabis withdrawal symptom relief: a randomized controlled trial.
    Gilbert DG; Rabinovich NE; McDaniel JT
    Psychopharmacology (Berl); 2020 May; 237(5):1507-1519. PubMed ID: 32034447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification: cannabis withdrawal syndrome and its correlation with delta-9-tetrahydrocannabinol and -metabolites in serum.
    Bonnet U; Specka M; Stratmann U; Ochwadt R; Scherbaum N
    Drug Alcohol Depend; 2014 Oct; 143():189-97. PubMed ID: 25127704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabis withdrawal in chronic, frequent cannabis smokers during sustained abstinence within a closed residential environment.
    Lee D; Schroeder JR; Karschner EL; Goodwin RS; Hirvonen J; Gorelick DA; Huestis MA
    Am J Addict; 2014; 23(3):234-42. PubMed ID: 24724880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacotherapies for cannabis dependence.
    Marshall K; Gowing L; Ali R; Le Foll B
    Cochrane Database Syst Rev; 2014; 12(12):CD008940. PubMed ID: 25515775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cannabis use and cannabis use disorders].
    Hoch E; Preuss UW
    Nervenarzt; 2024 Sep; 95(9):781-796. PubMed ID: 39134752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lithium carbonate in the management of cannabis withdrawal in humans: an open-label study.
    Winstock AR; Lea T; Copeland J
    J Psychopharmacol; 2009 Jan; 23(1):84-93. PubMed ID: 18515451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in striatal dopamine release, sleep, and behavior during spontaneous Δ-9-tetrahydrocannabinol abstinence in male and female mice.
    Kesner AJ; Mateo Y; Abrahao KP; Ramos-Maciel S; Pava MJ; Gracias AL; Paulsen RT; Carlson HB; Lovinger DM
    Neuropsychopharmacology; 2022 Jul; 47(8):1537-1549. PubMed ID: 35478010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.